Biguanide derivative 4C boosts talazoparib by triggering ferroptosis in bladder cancer
A new preclinical study reports that a previously underexplored biguanide-based compound, 4C, can dramatically enhance the anticancer effects of talazoparib ...
A new preclinical study reports that a previously underexplored biguanide-based compound, 4C, can dramatically enhance the anticancer effects of talazoparib ...
In a groundbreaking new study, researchers have opened an intriguing dialogue about the synergistic potential of combination therapies in treating ...
A groundbreaking advancement in the treatment of neuroendocrine tumors has emerged from a recent Phase I clinical trial, heralding a ...
In a groundbreaking advancement for metastatic colorectal cancer treatment, researchers from City of Hope have revealed promising results from a ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine